Syreon Corporation

What Syreon Corporation does

Syreon Corporation is a privately held contract research organization (CRO) founded in 1994 and headquartered in Vancouver, British Columbia, with a European headquarters in Budapest, Hungary operating as Syreon Research Institute. The company conducts international clinical trials across all phases (Phase 1 through Phase 4/post-marketing surveillance), health economics and outcomes research, computational analysis, and real-world evidence research for Fortune 500 pharmaceutical companies, top-20 global pharma, middle-tier biotechnology corporations, and early-phase biotech. Syreon maintains operations across 40+ countries through Regional Directors in North America, Latin America, Western Europe, Eastern Europe, the Middle East, and Australasia.

The company's core technology is ClinStream Cloud, a proprietary digital clinical research platform with 25 years of operational use. ClinStream integrates CTMS, 21 CFR Part 11-compliant EDC, ePRO, real-time randomization, IP management, and in-stream analytics into a single system, supported by Digital Research Networks linking 2,000+ research centers and up to 40,000 patients per study. Specialized service lines include precision medicine and biomarker-driven trials, adaptive trial design, real-world evidence generation, telemedicine monitoring, and the Syreon Research Institute's health economics, strategic pricing, value dossier, and HTA submission services.

Syreon generates revenue through contracted clinical research services and health economics advisory engagements with pharmaceutical and biotechnology sponsors. Pricing is project-specific and negotiated directly with sponsors based on study scope, therapeutic area, geographic reach, and complexity. The company employs 101-250 people, is GDPR and PIPEDA compliant, and operates as an independent private entity with no disclosed parent company or institutional shareholders. Its competitive position rests on a long-tenured client base with 30+ years of repeat business from top-tier pharma, an integrated proprietary platform, and global investigator networks.

Name

Syreon Corporation

Legal name

Syreon Corporation

Website

https://syreon.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

101–250 employees

Short description

Syreon Corporation is a privately held contract research organization conducting international clinical trials, health economics, computational analysis, and real-world evidence research for Fortune 500 pharma, top-20 global pharma, and emerging biotech across 40+ countries, anchored by its proprietary ClinStream Cloud platform.

Ownership category

akta.pro rank

Product category

Contract Research Organization (Clinical Research Services)

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro industry

PRIMARYHLAGAAAA

Clinical CROs (Phase I–IV)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGACAE

Clinical Trial Site Operations & Study Coordination

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Clinical Trial Services & Site Management (SMO)

SECONDARYHLAGAAAF

Clinical Data Management, Biostatistics & Statistical Programming CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAI

Patient Recruitment, Site Feasibility & Trial Enablement CROs

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

SECONDARYHLAGAAAL

Specialty Therapeutic-Area CROs (e.g., oncology/rare disease)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Contract Research Organizations (CRO)

Keywords

• Clinical research services
• Contract research organization
• Health economics research
• Real-world evidence research
• Clinical trial management

Headquarters

HQ city

Vancouver

HQ country

Canada

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Contract Research Services: Syreon provides end-to-end clinical research services including study planning, operation, and analysis across all phases from Phase 1 through Phase 4/post-marketing surveillance. Services are contracted directly with pharma and biotech sponsors on a project basis.
2. Health Economics and Outcomes Research: Syreon Research Institute provides systematic review, meta-analysis, economic modeling, strategic pricing, value dossiers, and health policy research services to pharmaceutical and biotechnology industry clients.
3. Digital Research Platform Licensing: The proprietary ClinStream Cloud platform and digital research networks are provided as part of integrated service offerings to support clinical trials and real-world evidence research.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels5 records

Core offering

Syreon Corporation is a contract research organization that plans, operates, and analyzes international clinical trials (Phase 1 through Phase 4/post-marketing surveillance) and provides health economics, outcomes research, computational analysis, and real-world evidence research for pharmaceutical and biotechnology sponsors. It delivers these services through its proprietary ClinStream Cloud digital research platform and a wholly-owned health economics subsidiary, supported by a global digital research network spanning 40+ countries.

Product overview

Syreon Corporation operates as a Contract Research Organization (CRO) offering a unified platform of clinical research services centered on its proprietary ClinStream Cloud platform. The ClinStream ecosystem comprises integrated modules including ClinStream EDC (electronic data capture) and ClinStream ePRO (patient-reported outcomes), both 21CFR Part 11 compliant, providing end-to-end study management from randomization through financial control. The company complements its digital platform with specialized service divisions: Syreon Research Institute (SRI) for health economics, modeling, strategic pricing and policy research; and specialized services for precision medicine/biomarkers, adaptive trial design, real-world evidence, and telemedicine monitoring. Digital Research Networks spanning 40+ countries with up to 40,000 patients support global trial operations across all phases and therapeutic areas.

Differentiator

Problem solved

Functional benefit

Products and services

• ClinStream Cloud Proprietary cloud-based digital clinical research platform that integrates data from all sources to enable overall study management, real-time randomization and IP management, site management, data visualization for in-stream analysis, study monitoring, and financial control. Provided to pharmaceutical and biotechnology sponsors as part of contracted clinical trial services.
• Digital Research Networks Global digital network linking leading academic institutions, community sites, patients and caregivers, providers, and payers in thousands of locations across more than 40 countries, capable of engaging up to 40,000 participating patients for real-time investigation of new treatments and health outcomes evaluation.
• Syreon Research Institute (SRI) Health economics and outcomes research division of Syreon providing systematic review and meta-analysis, resource utilization research, health economics modeling, strategic pricing, value dossiers, evidence-based policy research, and corporate training services to pharmaceutical and biotechnology industry clients.
• Precision Medicine Services Biomarker-guided therapy and adaptive trial services including predictive biomarkers, genetics and genomics, targeted proteomics, molecular diagnostics, pharmacometrics, and advanced imaging for personalized therapeutics development.
• Real-World Evidence (RWE) Services Real-world evidence services combining streams of real-world data including patient health data and resource utilization from electronic health records, claims, registries, and mobile devices to monitor postmarket safety, adverse events, and develop decision support tools for clinical practice.
• Adaptive Trial Design Services Agile adaptive trials and umbrella/basket trial designs permitting continuous evaluation of study outcomes, sequential addition of new cohorts, and incorporation of novel findings to select the most promising therapies.
• Health Economics and Modeling Services Comprehensive health economic analysis including cost-minimization, cost-effectiveness and cost-utility modeling, Markov models, Monte Carlo methods, discrete event simulation, and sophisticated sensitivity and scenario analysis for pharmaceutical and biotechnology sponsors.
• Strategic Pricing and Market Access Services Services ensuring products are optimally priced for rapid market uptake, tightly aligned with patient, provider, and payer needs, including value dossier creation, reimbursement strategy, and health technology assessment submission support.
• Telemedicine and Remote Monitoring

Quantifiable outcome

• Real-time investigation of new treatments with up to 40,000 participating patients across hundreds of sites in dozens of countries
• +3 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature6 records

Scale indicators7 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Medpace Holdings: Mid-size, US-headquartered full-service CRO with strong therapeutic specialization and high organic growth. Comparable to Syreon in offering Phase 1-4 clinical operations across complex therapeutic areas for biotech and pharma sponsors, though significantly larger.
• Worldwide Clinical Trials: Mid-tier, PE-backed global CRO focused on complex therapeutic areas in early and late-phase clinical research. Closely comparable to Syreon in size, therapeutic specialization, and midsize-CRO positioning serving top pharma and biotech.
• Clinipace Worldwide: Mid-sized, technology-forward CRO with adaptive trial design and therapeutic specialization. Comparable to Syreon in mid-market positioning, biometric/biostatistics emphasis, and focus on emerging and mid-tier biotech sponsors.
• Evidera (PPD/PharmaLex): HEOR, RWE, and market access consultancy embedded in a clinical research delivery organization. Highly comparable to Syreon Research Institute's HTA/value-dossier/market access work, often co-selling with the parent CRO.

Broad incumbents

• ICON plc: One of the world's largest CROs offering full-service clinical development plus decentralized and post-approval services. Overlaps broadly with Syreon's Phase 1-4 and HEOR/RWE offerings, but at significantly greater scale with global preferred-provider deals.
• IQVIA: Largest global CRO plus real-world evidence and technology franchise (Orchestrated Patient Engagement, EDC). Overlaps directly with Syreon's clinical operations, RWE, and analytics offerings, but at vastly greater scale with bundled solution-selling.
• Charles River Laboratories: Major CRO/preclinical CDMO offering discovery, safety, clinical, and manufacturing services. Comparable in serving biotech-to-pharma sponsors across the development lifecycle, with overlap in Syreon's clinical operations and biomarker work.
• Parexel International: Large global CRO (currently PE-owned) operating across all phases with strong biopharma footprint. Overlapping directly with Syreon's Phase 1-4 and DCT capabilities; comparable to Syreon's longstanding pharma/biotech client base.

Emerging players

• Clario (formerly ERT/BioTelemetry): Specialized provider of clinical trial endpoint technology (eCOG, ePRO, cardiac safety, imaging). Direct overlap with Syreon's ClinStream ePRO and telemedicine/remote monitoring modules and DCT infrastructure.

Others

• Oracle Health Sciences (Clinical One / Inform EDC): Vendor of EDC, CTMS, and randomization/MW platforms widely used by CROs and sponsors. Adjacent technology competitor to Syreon's ClinStream platform offering, particularly in CTMS/EDC infrastructure layering.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Syreon Corporation